Viewing Study NCT05315167


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-01-03 @ 1:24 PM
Study NCT ID: NCT05315167
Status: RECRUITING
Last Update Posted: 2024-12-17
First Post: 2022-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors
Sponsor: Zhuhai Yufan Biotechnologies Co., Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-05-30
Start Date Type: ACTUAL
Primary Completion Date: 2027-05-15
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-11-15
Completion Date Type: ESTIMATED
First Submit Date: 2022-03-29
First Submit QC Date: None
Study First Post Date: 2022-04-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-12-11
Last Update Post Date: 2024-12-17
Last Update Post Date Type: ACTUAL